Abstract

BLZ-100 is an optical contrast agent composed of chlorotoxin and indocyanine green. Clinical trials in multiple tumor types enabled evaluation of BLZ-100 with clinical imaging devices. Safety and imaging data support further clinical development.

© 2017 OSA

PDF Article